C-difficile is currently the most common hospital acquired infection—affecting half a million Americans every year. While one out of five patients fail to respond after the initial round of antibiotics, repeated doses of antibiotics remain the standard of care in most hospitals. But new research, that is finally catching up with antiquity (“yellow soup” discovered … Continue reading C-diff—can a Fecal Microbiota Transplant stop the recurrence?